Webb10 apr. 2024 · A high-level overview of SCYNEXIS, Inc. (SCYX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebbFör 1 dag sedan · Analyst Forecast. According to 11 analysts, the average rating for SCYX stock is "Buy." The 12-month stock price forecast is $13.84, which is an increase of …
SCYNEXIS, Inc News — NASDAQ:SCYX — TradingView
Webb30 mars 2024 · News stories and articles referencing SCYNEXIS on European Pharmaceutical Review. Recommended. ... Contact Subscribe Today. T: +44 (0)1959 … Webb22 mars 2024 · The latest Tweet by Bloomberg states, 'Scynexis, a pharmaceutical company that develops antifungal medicines, is on track for its largest two-day surge … india england t20 2017 highest runa
SCYNEXIS News Markets Insider
Webb5 apr. 2024 · SCYX Scynexis $3.46 / -0.105 (-2.95%) 03/30/23 Scynexis, GSK announce exclusive agreement to commercialize, develop Brexafemme 12/01/22 Scynexis announces FDA approval of second indication for BREXAFEMME 11/30/22 Scynexis announces $3M NIH grant awarded to study fungerp 11/17/22 Scynexis comments on … Webb30 mars 2024 · Today we provided an update on exciting corporate news. We will be hosting an investor call at 8:30 am EDT today. Learn more in our press… WebbGuggenheim moves SCYX price target from $8 to $9 (currently $3.61). Scynexis has a 2-week gain of 217% (+20% today). india england t20 2017 highlights